AKAM
43
3
PSA
51
-4
VRSN
53
3
HP
38
-2
LH
42
2
CAG
30
4
HOG
29
-4
MTCH
37
7
WDC
41
-2
GOOG
65
-4
GRMN
62
-3
UA
45
-3
AA
51
3
LUV
39
-5
CL
56
5
ABT
57
-5
DNB
78
6
EXPE
88
2
GM
65
-3
SCHW
64
2
AKAM
43
3
PSA
51
-4
VRSN
53
3
HP
38
-2
LH
42
2
CAG
30
4
HOG
29
-4
MTCH
37
7
WDC
41
-2
GOOG
65
-4
GRMN
62
-3
UA
45
-3
AA
51
3
LUV
39
-5
CL
56
5
ABT
57
-5
DNB
78
6
EXPE
88
2
GM
65
-3
SCHW
64
2
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

VRNA
Verona Pharma PLC

Last Price:
37.93
Seasonality Move:
21.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Verona Pharma PLC Price Quote

$37.93
-0.92 (-2.37%)
(Updated: November 21, 2024 at 5:55 PM ET)

Verona Pharma PLC Key Stats

Buy
55
Verona Pharma PLC (VRNA) is a Buy
Day range:
$37.86 - $39.58
52-week range:
$11.39 - $40.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
21.91%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
163.75%
Market cap:
$2.9B
Revenue:
$0
EPS:
$-2

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $120M
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $336M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 1.59

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.8M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $180.6M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45K

Verona Pharma PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    VRNA return on invested capital is -55.17%
  • What Is Verona Pharma PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -45.04%
  • What Is VRNA Return On Equity?
    ROE is a measure of profitability and is -74.15%

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -36.59%
Revenue: 0% 180.53%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 46.57
Upside from Last Price: 19.87%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    113.2M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders